Literature DB >> 17160708

The signaling mechanism of ROS in tumor progression.

Wen-Sheng Wu1.   

Abstract

Reactive oxygen species (ROS) are recently proposed to be involved in tumor metastasis which is a complicated processes including epithelial-mesenchymal transition (EMT), migration, invasion of the tumor cells and angiogenesis around the tumor lesion. ROS generation may be induced intracellularly, in either NADPH oxidase- or mitochondria-dependent manner, by growth factors and cytokines (such as TGFbeta and HGF) and tumor promoters (such as TPA) capable of triggering cell adhesion, EMT and migration. As a signaling messenger, ROS are able to oxidize the critical target molecules such as PKC and protein tyrosine phosphates (PTPs), which are relevant to tumor cell invasion. PKC contain multiple cysteine residues that can be oxidized and activated by ROS. Inactivation of multiple PTPs by ROS may relieve the tyrosine phosphorylation-dependent signaling. Two of the down-stream molecules regulated by ROS are MAPK and PAK. MAPKs cascades were established to be a major signal pathway for driving tumor cell metastasis, which are mediated by PKC, TGF-beta/Smad and integrin-mediated signaling. PAK is an effector of Rac-mediated cytoskeletal remodeling that is responsible for cell migration and angiogenesis. There are several transcriptional factors such as AP1, Ets, Smad and Snail regulating a lot of genes relevant to metastasis. AP-1 and Smad can be activated by PKC activator and TGF-beta1, respectively, in a ROS dependent manner. On the other hand, Est-1 can be upregulated by H2O2 via an antioxidant response element in the promoter. The ROS-regulated genes relevant to EMT and metastasis include E-cahedrin, integrin and MMP. Comprehensive understanding of the ROS-triggered signaling transduction, transcriptional activation and regulation of gene expressions will help strengthen the critical role of ROS in tumor progression and devising strategy for chemo-therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160708     DOI: 10.1007/s10555-006-9037-8

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  253 in total

1.  Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study.

Authors:  Raphaël Beck; Rozangela Curi Pedrosa; Nicolas Dejeans; Christophe Glorieux; Philippe Levêque; Bernard Gallez; Henryk Taper; Stéphane Eeckhoudt; Laurent Knoops; Pedro Buc Calderon; Julien Verrax
Journal:  Invest New Drugs       Date:  2010-05-08       Impact factor: 3.850

2.  Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy.

Authors:  Anne R Diers; Brian P Dranka; Karina C Ricart; Joo Yeun Oh; Michelle S Johnson; Fen Zhou; Manuel A Pallero; Thomas M Bodenstine; Joanne E Murphy-Ullrich; Danny R Welch; Aimee Landar
Journal:  Biochem J       Date:  2010-08-15       Impact factor: 3.857

3.  Design, synthesis, and evaluation of 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid derived, redox-sensitive contrast agents for magnetic resonance imaging.

Authors:  Natarajan Raghunand; Gerald P Guntle; Vijay Gokhale; Gary S Nichol; Eugene A Mash; Bhumasamudram Jagadish
Journal:  J Med Chem       Date:  2010-09-23       Impact factor: 7.446

4.  A Novel Sirtuin-3 Inhibitor, LC-0296, Inhibits Cell Survival and Proliferation, and Promotes Apoptosis of Head and Neck Cancer Cells.

Authors:  Turki Y Alhazzazi; Pachiyappan Kamarajan; Yanli Xu; Teng Ai; Liqiang Chen; Eric Verdin; Yvonne L Kapila
Journal:  Anticancer Res       Date:  2016-01       Impact factor: 2.480

Review 5.  Role of aquaporins in cell proliferation: What else beyond water permeability?

Authors:  Ana Galán-Cobo; Reposo Ramírez-Lorca; Miriam Echevarría
Journal:  Channels (Austin)       Date:  2016-01-11       Impact factor: 2.581

6.  Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesis.

Authors:  Yanyang Tu; Zhen Wang; Xin Wang; Hongwei Yang; Pengxing Zhang; Mark Johnson; Nan Liu; Hui Liu; Weilin Jin; Yongsheng Zhang; Daxiang Cui
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

7.  Selective induction of tumor cell apoptosis by a novel P450-mediated reactive oxygen species (ROS) inducer methyl 3-(4-nitrophenyl) propiolate.

Authors:  Xiaoxiao Sun; Midan Ai; Ying Wang; Shensi Shen; Yuan Gu; Yi Jin; Zuyu Zhou; Yaqiu Long; Qiang Yu
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

Review 8.  Cytoglobin in tumor hypoxia: novel insights into cancer suppression.

Authors:  Sankalpa Chakraborty; Rince John; Alo Nag
Journal:  Tumour Biol       Date:  2014-05-10

9.  Oxidative exposure impairs TGF-β pathway via reduction of type II receptor and SMAD3 in human skin fibroblasts.

Authors:  Tianyuan He; Taihao Quan; Yuan Shao; John J Voorhees; Gary J Fisher
Journal:  Age (Dordr)       Date:  2014-02-20

Review 10.  Molecular and Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System: Implications for Pathology.

Authors:  Salvatore Nesci; Fabiana Trombetti; Alessandra Pagliarani; Vittoria Ventrella; Cristina Algieri; Gaia Tioli; Giorgio Lenaz
Journal:  Life (Basel)       Date:  2021-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.